Source: Annual Congress 2011 - PG3 Workshop: Genomics and proteomics of lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
G. Marko-Varga (Lund, Sweden). The challenge of providing proteomic tools in clinical practice. Annual Congress 2011 - PG3 Workshop: Genomics and proteomics of lung disease

Member's Comments

No comment yet.

Related content which might interest you: Establishment of an integrated clinical network and comprehensive data warehouse for the conduct of comparative effectiveness research in COPD Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 New technologies in bronchoscopy: which are still research tools and which are ready for clinical use? Source: Annual Congress 2010 - PG13 Core Curriculum Postgraduate Course: Interventional pulmonology Year: 2010 State-of-the-art: development of evidence-based clinical practice guidelines Source: Annual Congress 2011 - PG13 ERS/ACCP jointly organised: evidence-based approach to advanced respiratory care Year: 2011 Multidimensional assessment methods for dyspnoea profiling in clinical practice and laboratory research Source: International Congress 2018 – Dyspnoea: a multidimensional and multidisciplinary approach Year: 2018 An evidence-based, point-of-care tool to guide completion of asthma action plans in practice Source: Eur Respir J, 49 (5) 1602238; 10.1183/13993003.02238-2016 Year: 2017 ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies Source: Virtual Congress 2020 – New developments in pandemic medicine Year: 2020 Opportunities and outstanding challenges for integration in clinical practice Source: Virtual Congress 2021 – Inhale the future: ambulatory sensing technologies, digital biomarkers and explainable insights Year: 2021 From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 What kind of emphasis do we need in clinical research to enable personalised respiratory medicine? Source: Eur Respir J, 55 (1) 1901866; 10.1183/13993003.01866-2019 Year: 2020 Using qualitative methods to explore the implementation of diagnostics in primary care Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course Year: 2019 Proteomic research tools for respiratory medicine Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 The impact of hands-on respiratory management for physicians in clinical practice and its future perspective Source: Annual Congress 2012 - Improving education for the healthcare team and patients Year: 2012 Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018 What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016 What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008 Starting clinical research in a limited resource environment Source: International Congress 2014 – ME06 Starting clinical research in a limited resource environment Year: 2014 How to implement this approach in clinical practice in primary care Source: ERS Research Seminar 2017 – Precision medicine in airway diseases Year: 2017 Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008 How pharmacokinetic/pharmacodynamic science informs dosage recommendations? Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice Year: 2010